Kim A. Margolin MD

Dr. Margolin specializes in melanoma and other skin cancers with a focus on immunotherapy. She came to Providence/St. John’s from the City of Hope, where she worked for a total of 30 years, stopping out for 6 years at the University of Washington and 1 year at Stanford.

Dr. Margolin has co-led the Cytokine Working Group and the Cancer Immunotherapy Trials Network, participated in SWOG’s Melanoma Committee and served ASCO and the Society for Immunotherapy of Cancer in many capacities. She has served on the FDA’s Oncology Drugs Advisory Committee and has been on two advisory committees to the European Organization for the Research and Treatment of Cancer.

Among her research interests is brain metastasis in melanoma and immunotherapy of skin cancers. Dr. Margolin will collaborate with surgeons and laboratory investigators at St. John’s and will lead the institute’s efforts in melanoma/skin cancer clinical trials.